1. Home
  2. HSAI vs BHVN Comparison

HSAI vs BHVN Comparison

Compare HSAI & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hesai Group each ADS represents one Class B ordinary share

HSAI

Hesai Group each ADS represents one Class B ordinary share

BUY

Current Price

$12.97

Market Cap

2.4B

Sector

N/A

ML Signal

BUY

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

HOLD

Current Price

$11.38

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HSAI
BHVN
Founded
2014
2013
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.1B
IPO Year
2021
2022

Fundamental Metrics

Financial Performance
Metric
HSAI
BHVN
Price
$12.97
$11.38
Analyst Decision
Strong Buy
Buy
Analyst Count
19
17
Target Price
★ $28.03
$21.27
AVG Volume (30 Days)
1.0M
★ 1.9M
Earning Date
11-10-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 26.08
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$41.54
N/A
Revenue Next Year
$41.46
N/A
P/E Ratio
$61.18
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.36
$7.48
52 Week High
$29.35
$18.57

Technical Indicators

Market Signals
Indicator
HSAI
BHVN
Relative Strength Index (RSI) 31.13 40.23
Support Level N/A $10.75
Resistance Level $19.29 $12.03
Average True Range (ATR) 0.49 0.62
MACD -0.30 -0.10
Stochastic Oscillator 14.11 24.62

Price Performance

Historical Comparison
HSAI
BHVN

About HSAI Hesai Group each ADS represents one Class B ordinary share

Hesai Group is engaged in the development, manufacture, and sales of three-dimensional light detection and ranging solutions, or LiDAR. Its LiDAR products enable a broad spectrum of applications across passenger or commercial vehicles with enhanced driver assistance systems, or ADAS, autonomous vehicle fleets providing passenger and freight mobility services, or Autonomous Mobility, and other applications such as last-mile delivery robots, street sweeping robots, and logistics robots in restricted areas, or Robotics. Geographically, the company operates in North America, Mainland China, Europe, and Other regions.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.

Share on Social Networks: